Luis Martínez-Granados
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Luis Martínez-Granados has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
José Antonio Castilla
Unidad de Reproducción, UGC de Laboratorio Clínico y UGC Obstetricia y Ginecología, HU Virgen de las Nieves, Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain; Departamento Anatomía y Embriología Humana, Facultad de Medicina, Universidad de Granada, Granada, Spain; CEIFER Biobanco, Granada, Spain
5 shared publicationsAntonio González-Utor
Centro MasVida Reproducción, Sevilla, Spain
3 shared publicationsFernando Prados
Hospital Universitario Montepríncipe, Madrid, España
3 shared publicationsIrene Cuevas
Hospital General Universitario, Valencia, España
3 shared publicationsM. Carmen Gonzalvo
Unidad de Reproducción Humana, UGC Laboratorio Clínico y UGC Obstetricia y Ginecología, Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, España
3 shared publicationsMaría Serrano
Clínica IFEM, Córdoba, Spain
3 shared publications
Latest Publications
- 1 November 2018
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 230, 55-59
Application of a sperm survival test: Results from an external quality control programme
- 1 November 2018
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 230, 55-59
Application of a sperm survival test: Results from an external quality control programme
- 1 March 2018
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 36 (3) , 259-268
Reliability and agreement on embryo assessment: 5 years of an external quality control programme
- 1 March 2018
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 36 (3) , 259-268
Reliability and agreement on embryo assessment: 5 years of an external quality control programme
- 1 January 2018
- Published by Elsevier in Medicina Reproductiva y Embriología Clínica
- Vol. 5 (1) , 11-18
Análisis de la evolución de las especificaciones de los indicadores de calidad del laboratorio de reproducción asistida humana (UNE 179007)
- 1 January 2018
- Published by Elsevier in Medicina Reproductiva y Embriología Clínica
- Vol. 5 (1) , 11-18
Análisis de la evolución de las especificaciones de los indicadores de calidad del laboratorio de reproducción asistida humana (UNE 179007)
- 1 September 2017
- Published by Elsevier in Medicina Reproductiva y Embriología Clínica
- Vol. 4 (3) , 136-142
Registro de inseminación artificial de la Sociedad Española de Fertilidad de los años 2012 y 2013
- 1 September 2017
- Published by Elsevier in Medicina Reproductiva y Embriología Clínica
- Vol. 4 (3) , 136-142
Registro de inseminación artificial de la Sociedad Española de Fertilidad de los años 2012 y 2013
- 1 September 2017
- Published by Elsevier in Medicina Reproductiva y Embriología Clínica
- Vol. 4 (3) , 143-153
Registro FIV/ICSI de la Sociedad Española de Fertilidad de los años 2012 y 2013
- 1 September 2017
- Published by Elsevier in Medicina Reproductiva y Embriología Clínica
- Vol. 4 (3) , 143-153
Registro FIV/ICSI de la Sociedad Española de Fertilidad de los años 2012 y 2013
- 1 September 2017
- Published by Elsevier in Medicina Reproductiva y Embriología Clínica
- Vol. 4 (3) , 122-127
Indicadores de calidad del laboratorio de reproducción: Manual de Buena Práctica Clínica de la SEF versus Grupo de Interés de Calidad de ASEBIR
- 1 September 2017
- Published by Elsevier in Medicina Reproductiva y Embriología Clínica
- Vol. 4 (3) , 122-127
Indicadores de calidad del laboratorio de reproducción: Manual de Buena Práctica Clínica de la SEF versus Grupo de Interés de Calidad de ASEBIR
- 1 September 2017
- Published by Elsevier in Medicina Reproductiva y Embriología Clínica
- Vol. 4 (3) , 128-135
Análisis modal de fallos y efectos en la fase pretécnica del Laboratorio de Reproducción
- 1 September 2017
- Published by Elsevier in Medicina Reproductiva y Embriología Clínica
- Vol. 4 (3) , 128-135
Análisis modal de fallos y efectos en la fase pretécnica del Laboratorio de Reproducción
- Open Access
- 25 August 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (8) , e0183328
Inter-laboratory agreement on embryo classification and clinical decision: Conventional morphological assessment vs. time lapse
The aim of this study is to determine inter-laboratory variability on embryo assessment using time-lapse platform and conventional morphological assessment. This study compares the data obtained from a pilot study of external quality control (EQC) of time lapse, performed in 2014, with the classical EQC of the Spanish Society for the Study of Reproductive Biology (ASEBIR) performed in 2013 and 2014. In total, 24 laboratories (8 using EmbryoScope™, 15 using Primo Vision™ and one with both platforms) took part in the pilot study. The clinics that used EmbryoScope™ analysed 31 embryos and those using Primo Vision™ analysed 35. The classical EQC was implemented by 39 clinics, based on an analysis of 25 embryos per year. Both groups were required to evaluate various qualitative morphological variables (cell fragmentation, the presence of vacuoles, blastomere asymmetry and multinucleation), to classify the embryos in accordance with ASEBIR criteria and to stipulate the clinical decision taken. In the EQC time-lapse pilot study, the groups were asked to determine, as well as the above characteristics, the embryo development times, the number, opposition and size of pronuclei, the direct division of 1 into 3 cells and/or of 3 into 5 cells and false divisions. The degree of agreement was determined by calculating the intra-class correlation coefficients and the coefficient of variation for the quantitative variables and the Gwet index for the qualitative variables. For both EmbryoScope™ and Primo Vision™, two periods of greater inter-laboratory variability were observed in the times of embryo development events. One peak of variability was recorded among the laboratories addressing the first embryo events (extrusion of the second polar body and the appearance of pronuclei); the second peak took place between the times corresponding to the 8-cell and morula stages. In most of the qualitative variables analysed regarding embryo development, there was almost-perfect inter-laboratory agreement among conventional morphological assessment (CMA), EmbryoScope™ and Primo Vision™, except for false divisions, vacuoles and asymmetry (users of all methods) and multinucleation (users of Primo Vision™), where the degree of agreement was lower. The inter-laboratory agreement on embryo classification according to the ASEBIR criteria was moderate-substantial (Gwet 0.41–0.80) for the laboratories using CMA and EmbryoScope™, and fair-moderate (Gwet 0.21–0.60) for those using Primo Vision™. The inter-laboratory agreement for clinical decision was moderate (Gwet 0.41–0.60) on day 5 for CMA users and almost perfect (Gwet 0.81–1) for time-lapse users. In conclusion, time-lapse technology does not improve inter-laboratory agreement on embryo classification or the analysis of each morphological variable. Moreover, depending on the time-lapse platform used, inter-laboratory agreement may be lower than that obtained by CMA. However, inter-laboratory agreement on clinical decisions is improved with the use of time lapse, regardless of the platform used.
- 25 August 2017
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (8) , e0183328
Open AccessInter-laboratory agreement on embryo classification and clinical decision: Conventional morphological assessment vs. time lapse
The aim of this study is to determine inter-laboratory variability on embryo assessment using time-lapse platform and conventional morphological assessment. This study compares the data obtained from a pilot study of external quality control (EQC) of time lapse, performed in 2014, with the classical EQC of the Spanish Society for the Study of Reproductive Biology (ASEBIR) performed in 2013 and 2014. In total, 24 laboratories (8 using EmbryoScope™, 15 using Primo Vision™ and one with both platforms) took part in the pilot study. The clinics that used EmbryoScope™ analysed 31 embryos and those using Primo Vision™ analysed 35. The classical EQC was implemented by 39 clinics, based on an analysis of 25 embryos per year. Both groups were required to evaluate various qualitative morphological variables (cell fragmentation, the presence of vacuoles, blastomere asymmetry and multinucleation), to classify the embryos in accordance with ASEBIR criteria and to stipulate the clinical decision taken. In the EQC time-lapse pilot study, the groups were asked to determine, as well as the above characteristics, the embryo development times, the number, opposition and size of pronuclei, the direct division of 1 into 3 cells and/or of 3 into 5 cells and false divisions. The degree of agreement was determined by calculating the intra-class correlation coefficients and the coefficient of variation for the quantitative variables and the Gwet index for the qualitative variables. For both EmbryoScope™ and Primo Vision™, two periods of greater inter-laboratory variability were observed in the times of embryo development events. One peak of variability was recorded among the laboratories addressing the first embryo events (extrusion of the second polar body and the appearance of pronuclei); the second peak took place between the times corresponding to the 8-cell and morula stages. In most of the qualitative variables analysed regarding embryo development, there was almost-perfect inter-laboratory agreement among conventional morphological assessment (CMA), EmbryoScope™ and Primo Vision™, except for false divisions, vacuoles and asymmetry (users of all methods) and multinucleation (users of Primo Vision™), where the degree of agreement was lower. The inter-laboratory agreement on embryo classification according to the ASEBIR criteria was moderate-substantial (Gwet 0.41–0.80) for the laboratories using CMA and EmbryoScope™, and fair-moderate (Gwet 0.21–0.60) for those using Primo Vision™. The inter-laboratory agreement for clinical decision was moderate (Gwet 0.41–0.60) on day 5 for CMA users and almost perfect (Gwet 0.81–1) for time-lapse users. In conclusion, time-lapse technology does not improve inter-laboratory agreement on embryo classification or the analysis of each morphological variable. Moreover, depending on the time-lapse platform used, inter-laboratory agreement may be lower than that obtained by CMA. However, inter-laboratory agreement on clinical decisions is improved with the use of time lapse, regardless of the platform used.